Bronchiectasis Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: BD4BB1E3B4BDEN
Market Monitor Global

Abstracts

Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.

This report contains market size and forecasts of Bronchiectasis Drugs in Global, including the following market information:

Global Bronchiectasis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bronchiectasis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bronchiectasis Drugs include Endo International Plc, GlaxoSmithKline Plc, Neopharma LLC, Pfizer Inc. and Reckitt Benckiser Group Plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bronchiectasis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bronchiectasis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bronchiectasis Drugs Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Expectorants
• Other drugs

Global Bronchiectasis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bronchiectasis Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Research institute
• Clinic
• Other

Global Bronchiectasis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bronchiectasis Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bronchiectasis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bronchiectasis Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Endo International Plc
• GlaxoSmithKline Plc
• Neopharma LLC
• Pfizer Inc.
• Reckitt Benckiser Group Plc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bronchiectasis Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bronchiectasis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRONCHIECTASIS DRUGS OVERALL MARKET SIZE

2.1 Global Bronchiectasis Drugs Market Size: 2021 VS 2028
2.2 Global Bronchiectasis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bronchiectasis Drugs Players in Global Market
3.2 Top Global Bronchiectasis Drugs Companies Ranked by Revenue
3.3 Global Bronchiectasis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Bronchiectasis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bronchiectasis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bronchiectasis Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Bronchiectasis Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bronchiectasis Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bronchiectasis Drugs Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Expectorants
  4.1.4 Other drugs
4.2 By Type - Global Bronchiectasis Drugs Revenue & Forecasts
  4.2.1 By Type - Global Bronchiectasis Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Bronchiectasis Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Bronchiectasis Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bronchiectasis Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Research institute
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global Bronchiectasis Drugs Revenue & Forecasts
  5.2.1 By Application - Global Bronchiectasis Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Bronchiectasis Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Bronchiectasis Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bronchiectasis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Bronchiectasis Drugs Revenue & Forecasts
  6.2.1 By Region - Global Bronchiectasis Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Bronchiectasis Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Bronchiectasis Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bronchiectasis Drugs Revenue, 2017-2028
  6.3.2 US Bronchiectasis Drugs Market Size, 2017-2028
  6.3.3 Canada Bronchiectasis Drugs Market Size, 2017-2028
  6.3.4 Mexico Bronchiectasis Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bronchiectasis Drugs Revenue, 2017-2028
  6.4.2 Germany Bronchiectasis Drugs Market Size, 2017-2028
  6.4.3 France Bronchiectasis Drugs Market Size, 2017-2028
  6.4.4 U.K. Bronchiectasis Drugs Market Size, 2017-2028
  6.4.5 Italy Bronchiectasis Drugs Market Size, 2017-2028
  6.4.6 Russia Bronchiectasis Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Bronchiectasis Drugs Market Size, 2017-2028
  6.4.8 Benelux Bronchiectasis Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bronchiectasis Drugs Revenue, 2017-2028
  6.5.2 China Bronchiectasis Drugs Market Size, 2017-2028
  6.5.3 Japan Bronchiectasis Drugs Market Size, 2017-2028
  6.5.4 South Korea Bronchiectasis Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Bronchiectasis Drugs Market Size, 2017-2028
  6.5.6 India Bronchiectasis Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bronchiectasis Drugs Revenue, 2017-2028
  6.6.2 Brazil Bronchiectasis Drugs Market Size, 2017-2028
  6.6.3 Argentina Bronchiectasis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bronchiectasis Drugs Revenue, 2017-2028
  6.7.2 Turkey Bronchiectasis Drugs Market Size, 2017-2028
  6.7.3 Israel Bronchiectasis Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Bronchiectasis Drugs Market Size, 2017-2028
  6.7.5 UAE Bronchiectasis Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Endo International Plc
  7.1.1 Endo International Plc Corporate Summary
  7.1.2 Endo International Plc Business Overview
  7.1.3 Endo International Plc Bronchiectasis Drugs Major Product Offerings
  7.1.4 Endo International Plc Bronchiectasis Drugs Revenue in Global Market (2017-2022)
  7.1.5 Endo International Plc Key News
7.2 GlaxoSmithKline Plc
  7.2.1 GlaxoSmithKline Plc Corporate Summary
  7.2.2 GlaxoSmithKline Plc Business Overview
  7.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Major Product Offerings
  7.2.4 GlaxoSmithKline Plc Bronchiectasis Drugs Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Plc Key News
7.3 Neopharma LLC
  7.3.1 Neopharma LLC Corporate Summary
  7.3.2 Neopharma LLC Business Overview
  7.3.3 Neopharma LLC Bronchiectasis Drugs Major Product Offerings
  7.3.4 Neopharma LLC Bronchiectasis Drugs Revenue in Global Market (2017-2022)
  7.3.5 Neopharma LLC Key News
7.4 Pfizer Inc.
  7.4.1 Pfizer Inc. Corporate Summary
  7.4.2 Pfizer Inc. Business Overview
  7.4.3 Pfizer Inc. Bronchiectasis Drugs Major Product Offerings
  7.4.4 Pfizer Inc. Bronchiectasis Drugs Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Inc. Key News
7.5 Reckitt Benckiser Group Plc
  7.5.1 Reckitt Benckiser Group Plc Corporate Summary
  7.5.2 Reckitt Benckiser Group Plc Business Overview
  7.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Major Product Offerings
  7.5.4 Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue in Global Market (2017-2022)
  7.5.5 Reckitt Benckiser Group Plc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bronchiectasis Drugs Market Opportunities & Trends in Global Market
Table 2. Bronchiectasis Drugs Market Drivers in Global Market
Table 3. Bronchiectasis Drugs Market Restraints in Global Market
Table 4. Key Players of Bronchiectasis Drugs in Global Market
Table 5. Top Bronchiectasis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bronchiectasis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bronchiectasis Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bronchiectasis Drugs Product Type
Table 9. List of Global Tier 1 Bronchiectasis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bronchiectasis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bronchiectasis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bronchiectasis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bronchiectasis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bronchiectasis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bronchiectasis Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bronchiectasis Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bronchiectasis Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bronchiectasis Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bronchiectasis Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bronchiectasis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bronchiectasis Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Endo International Plc Corporate Summary
Table 31. Endo International Plc Bronchiectasis Drugs Product Offerings
Table 32. Endo International Plc Bronchiectasis Drugs Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Plc Corporate Summary
Table 34. GlaxoSmithKline Plc Bronchiectasis Drugs Product Offerings
Table 35. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Neopharma LLC Corporate Summary
Table 37. Neopharma LLC Bronchiectasis Drugs Product Offerings
Table 38. Neopharma LLC Bronchiectasis Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Inc. Corporate Summary
Table 40. Pfizer Inc. Bronchiectasis Drugs Product Offerings
Table 41. Pfizer Inc. Bronchiectasis Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Reckitt Benckiser Group Plc Corporate Summary
Table 43. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Offerings
Table 44. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bronchiectasis Drugs Segment by Type in 2021
Figure 2. Bronchiectasis Drugs Segment by Application in 2021
Figure 3. Global Bronchiectasis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bronchiectasis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bronchiectasis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bronchiectasis Drugs Revenue in 2021
Figure 8. By Type - Global Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 12. US Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 24. China Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bronchiectasis Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bronchiectasis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Endo International Plc Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Plc Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Neopharma LLC Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Inc. Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Reckitt Benckiser Group Plc Bronchiectasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)